CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,823 JPY | +0.52% |
|
-3.25% | -9.72% |
| 05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| 05-01 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
2024-06-26
- Ex-dividend day for interim dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,823
JPY
Average target price
6,021
JPY
Spread / Average Target
+24.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.72% | 50.47B | |
| +31.37% | 588B | |
| -2.99% | 364B | |
| +19.78% | 326B | |
| +5.19% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.66% | 167B | |
| +0.49% | 161B |
- Stock Market
- Equities
- 4519 Stock
- Funds and ETFs Chugai Pharmaceutical Co., Ltd